Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Bluebird Bio News
BLUE
BLUEBIRD BIO INC
0.91
-0.95%
BLUE
BLUEBIRD BIO INC
0.91
-0.95%
Prediction markets for Bluebird Bio
Prediction markets for Bluebird Bio
Will 50 Americans have been confirmed to have been cured of thalassemia through gene therapy by the end of 2024?
Jan 16, 3:18 PM
Jan 1, 4:59 AM
78%
chance
6
75
Option
Votes
NO
YES
185
103
Articles
Latest stories
12-Year-Old First to Receive Bluebird Bio's $3.1M Sickle Cell Gene Therapy Amid Vertex Transparency Issues
Authors
16
2 months
Bio
Science
Bluebird Bio to Restate 2022-2023 Financials Over Contract Manufacturing Errors
Authors
4
3 months
Bio
Science
Breakthrough Sickle Cell Therapies' 7-Figure Cost Poses Access Challenges
Authors
4
4 months
Economics
Business
Bluebird Bio ($BLUE) Offering at $1.50, Stock Plummets 42% Pre-Market, Raising $125M
Authors
6
7 months
Economics
Business
Bluebird Bio Faces Survival Concerns After Sick-Cell Therapy Mispricing, Potential Sale
Authors
5
7 months
Economics
Business
FDA Approves Bluebird Bio's Lyfengia with Black Box Warning; Vertex's Casgevy Priced at $2.2 Million, Shares Plunge 42%
Authors
4
7 months
Economics
Business
Previous
Next